Christopher Stepanian

Windgap Medical Announces Partnership with ALK-Abelló to Commercialize Novel ‘Wet/Dry’ Epinephrine...

News Wire ~ 3rd Party Press Release - 2019/08/09

Novel auto-injector is designed to address many unmet patient needs like portability, temperature stability, ease-of-use, and long shelf-life.

Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million

Dave Bloom - 2019/01/21

Windgap Medical is securing funding to continue development.

Delivering the Next Generation Auto-Injector

Dave Bloom - 2016/06/29

CEO Christopher Stepanian tells us how Windgap's auto-injector seeks to 'improve the quality of life for patients living with severe allergies.'

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: Christopher Stepanian

Windgap Medical Announces Partnership with ALK-Abelló to Commercialize Novel ‘Wet/Dry’ Epinephrine...

Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million

Delivering the Next Generation Auto-Injector